Literature DB >> 2578197

Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein.

M Sabara, J E Gilchrist, G R Hudson, L A Babiuk.   

Abstract

The 38,200-molecular weight (unreduced)/41,900-molecular-weight (reduced) glycoprotein of bovine rotavirus, isolate C486, was identified as the major neutralizing antigen. This glycoprotein as well as the corresponding glycoprotein of another bovine rotavirus serotype also specifically attached to cell monolayers under normal conditions for virus adsorption in vitro. Further support for this glycoprotein being directly responsible for virus attachment to cells was that (i) infectious virus of both serotypes could compete with the C486 glycoprotein for cell surface receptors, and (ii) neutralizing monospecific antiserum and neutralizing monoclonal antibodies directed toward the glycoprotein could block this virus-cell interaction. Preliminary epitope mapping of the glycoprotein with monoclonal antibodies further localized the neutralization-adsorption domain to a peptide with an approximate molecular weight of 14,000. The effect of two protein modifications, glycosylation and disulfide bridging, on the reactivity of this peptide with antibodies and cell surface receptors was investigated. It was demonstrated that, whereas glycosylation did not appear to affect these reactivities, disulfide bridging seemed to be essential.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578197      PMCID: PMC254978     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Formation of intermolecular disulfide bonds on nascent immunoglobulin polypeptides.

Authors:  L W Bergman; W M Kuehl
Journal:  J Biol Chem       Date:  1979-07-10       Impact factor: 5.157

2.  Infantile enteritis viruses: morphogenesis and morphology.

Authors: 
Journal:  J Virol       Date:  1975-10       Impact factor: 5.103

3.  Rotavirus isolation and cultivation in the presence of trypsin.

Authors:  L A Babiuk; K Mohammed; L Spence; M Fauvel; R Petro
Journal:  J Clin Microbiol       Date:  1977-12       Impact factor: 5.948

4.  Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

Authors:  D W Cleveland; S G Fischer; M W Kirschner; U K Laemmli
Journal:  J Biol Chem       Date:  1977-02-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Location of type-specific antigens in calf rotaviruses.

Authors:  J C Bridger
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

7.  Antibody to hepatitis B surface antigen after a single inoculation of uncoupled synthetic HBsAg peptides.

Authors:  G R Dreesman; Y Sanchez; I Ionescu-Matiu; J T Sparrow; H R Six; D L Peterson; F B Hollinger; J L Melnick
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

8.  Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine.

Authors:  D G Kleid; D Yansura; B Small; D Dowbenko; D M Moore; M J Grubman; P D McKercher; D O Morgan; B H Robertson; H L Bachrach
Journal:  Science       Date:  1981-12-04       Impact factor: 47.728

9.  A simple method for detecting antibodies to rubella.

Authors:  A Voller; D E Bidwell
Journal:  Br J Exp Pathol       Date:  1975-08

10.  Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses.

Authors:  R Leavitt; S Schlesinger; S Kornfeld
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  41 in total

1.  Ionic strength- and temperature-induced K(Ca) shifts in the uncoating reaction of rotavirus strains RF and SA11: correlation with membrane permeabilization.

Authors:  Sandra Martin; Mathie Lorrot; Mounia Alaoui El Azher; Monique Vasseur
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Trypsin cleavage stabilizes the rotavirus VP4 spike.

Authors:  S E Crawford; S K Mukherjee; M K Estes; J A Lawton; A L Shaw; R F Ramig; B V Prasad
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

3.  Specific interactions between rotavirus outer capsid proteins VP4 and VP7 determine expression of a cross-reactive, neutralizing VP4-specific epitope.

Authors:  D Y Chen; M K Estes; R F Ramig
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

4.  Integrins alpha2beta1 and alpha4beta1 can mediate SA11 rotavirus attachment and entry into cells.

Authors:  M J Hewish; Y Takada; B S Coulson
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Bovine herpesvirus type 1 gp87 mediates both attachment of virions to susceptible cells and hemagglutination.

Authors:  K Okazaki; E Honda; T Minetoma; T Kumagai
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

6.  Assembly of double-shelled rotaviruslike particles by simultaneous expression of recombinant VP6 and VP7 proteins.

Authors:  M Sabara; M Parker; P Aha; C Cosco; E Gibbons; S Parsons; L A Babiuk
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

7.  Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.

Authors:  F M Ruggeri; H B Greenberg
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Rotavirus genome segment 4 determines viral replication phenotype in cultured liver cells (HepG2).

Authors:  R F Ramig; K L Galle
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

9.  Rotavirus-specific protein synthesis is not necessary for recognition of infected cells by virus-specific cytotoxic T lymphocytes.

Authors:  P A Offit; H B Greenberg; K I Dudzik
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

10.  Bovine rotavirus type detection by neutralizing monoclonal antibodies.

Authors:  E Cornaglia; Y Elazhary; B Talbot
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.